The rise in the number of chronic obstructive pulmonary disease (COPD), TB, asthma, and pneumonia cases remains the major drivers of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). Asthma is one of the key indicators of this market, which affects children, adults, and elderly people. According to a European Respiratory Journal , the prevalence of asthma in France is estimated to be around 6.4% in 2018. Thus, with these factors, the adoption rate and demand for respiratory diseases are expected to grow substantially, over the forecast period.
Key Market Trends
Spirometers Segment is Expected to Show Better Growth in the Forecast Years
Based on diagnostic and monitoring devices segment, it is categorized into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs and others. The main factor attributing to the growth of spirometers segment is the increasing burden of respiratory disorders, such as asthma, bronchitis, and COPD across the country. The wide application of spirometers makes it easier for the patients to use this device and is thus, increasingly adopted in hospitals and home care settings. Furthermore, the significant advancements in the field of spirometry include the development of small portable spirometers and the increasing accuracy and acceptability, which is expected to fuel the market growth over the forecast period.
Competitive Landscape
The global players into the France respiratory devices market are Dragerwerk AG, Drive Devilbiss International, Fisher & Paykel Healthcare Limited, GE Healthcare, GlaxoSmithKline PLC, Invacare Corporation, Koninklijke Philips N.V, Medtronic PLC and ResMed Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
Methodology
LOADING...
